
- U.S. Code - Title 15: Commerce and Trade - 15 USC 77 - Sec. 77. Discrimination against neutral Americans in time of war
- Code of Federal Regulations - Title 17: Commodity and Securities Exchanges - 17 CFR 240.10b-5 - Employment of manipulative and deceptive devices.
- U.S. Supreme Court - Merrill Lynch, Pierce, Fenner & Smith, Inc. v. Curran, 456 U.S. 353 (1982)
- U.S. Supreme Court - Steadman v. SEC, 450 U.S. 91 (1981)
- U.S. Supreme Court - Vance v. Terrazas, 444 U.S. 252 (1980)
U.S. Supreme Court HERMAN & MacLEAN v. HUDDLESTON, 459 U.S. 375 (1983) 459 U.S. 375
HERMAN & MacLEAN v. HUDDLESTON ET AL. CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT No. 81-680. Argued November 9, 1982 Decided January 24, 1983* Alleging that they were defrauded by misrepresentations in a registration statement and prospectus for certain securities, purchasers of such securities brought a class action in Federal District Court against most of the participants in the offering, seeking recovery under 10(b) of the Securities Exchange Act of 1934 (1934 Act), which makes it unlawful for "any" person to use "any" manipulative or deceptive device or contrivance in the purchase or sale of "any" security. The trial judge instructed the jury to determine whether the plaintiffs had proved their cause of action by a preponderance of the evidence, and judgment was entered on the basis of a jury verdict in plaintiffs' favor. The Court of Appeals held that a cause of action may be maintained under 10(b) for fraudulent misrepresentations and omissions even when, as in this case, that conduct might also be actionable under 11 of the Securities Act of 1933 (1933 Act), which expressly allows purchasers of a registered security to sue certain enumerated parties who play a direct role in a registered offering when false or misleading information is included in a registration statement. However, the Court of Appeals concluded that a plaintiff seeking recovery under 10(b) of the 1934 Act must prove his case by "clear and convincing" evidence, and reversed and remanded on other grounds. Held: 1. The availability of an express remedy under 11 of the 1933 Act does not preclude defrauded purchasers of registered securities from maintaining an action under 10(b) of the 1934 Act. Pp. 380-387. (a) The two provisions involve distinct causes of action and were intended to address different types of wrongdoing. Under 11, a plaintiff need only show a material misstatement or omission in a registration statement to establish a prima facie case. Such an action must be brought by a purchaser of a registered security, and can only be brought against certain parties. In contrast, 10(b) is a "catchall" antifraud provision and requires a purchaser or seller of a security, in order to establish a cause of action, to prove that the defendant acted with scienter. Pp. 380-382. [Page 459 U.S. 375, 376] (b) To exempt conduct actionable under 11 from liability under 10(b) would conflict with the basic purpose of the 1933 Act: to provide greater protection to purchasers of registered securities. It is hardly a novel proposition that the two Acts prohibit some of the same conduct. Cf. Ernst & Ernst v. Hochfelder, 425 U.S. 185. A cumulative construction of the remedies under the Acts is also supported by the fact that when Congress comprehensively revised the securities laws in 1975, federal courts had consistently recognized an implied private right of action under 10(b) even where express remedies under 11 or other provisions were available. A cumulative construction of the securities laws also furthers their broad remedial purposes. Pp. 382-387. 2. Persons seeking recovery under 10(b) need prove their cause of action by a preponderance of the evidence only, not by clear and convincing evidence. The preponderance standard has been consistently employed in private actions under the securities laws. Cf. SEC v. C. M. Joiner Leasing Corp., 320 U.S. 344. Reference to the traditional use of a higher burden of proof in civil fraud actions at common law is unavailing here. An important purpose of the federal securities statutes was to rectify perceived deficiencies in the available common-law protections by establishing higher standards of conduct in the securities industry. The balance of the parties' interests in this case warrants use of the preponderance standard, which allows both parties to share the risk of error in roughly equal fashion. While defendants face the risk of opprobrium that may result from a finding of fraudulent conduct, defrauded investors are among the very individuals Congress sought to protect in the securities laws, and if they prove that it is more likely than not that they were defrauded, they should recover. Pp. 387-391. 640 F.2d 534, affirmed in part, reversed in part, and remanded. MARSHALL, J., delivered the opinion of the Court, in which all other Members joined, except POWELL, J., who took no part in the decision of the cases. [Footnote *] Together with No. 81-1076, Huddleston et al. v. Herman & MacLean et al., also on certiorari to the same court. James L. Truitt argued the cause for Herman & MacLean. With him on the briefs was Jack Pew, Jr. Robert H. Jaffe argued the cause for respondents in No. 81-680 and petitioners in No. 81-1076. With him on the brief were Myer Feldman, Jonathan M. Weisgall, Robert L. Deitz, and David S. Komiss. [Page 459 U.S. 375, 377] Paul Gonson argued the cause for the Securities and Exchange Commission as amicus curiae. With him on the brief urging affirmance in part and reversal in part were Solicitor General Lee, Deputy Solicitor General Shapiro, Jacob H. Stillman, and Richard A. Kirby.Fn Fn [Page 459 U.S. 375, 377] William E. Hegarty, Victor M. Earle III, and Joseph W. Muccia filed a brief for Peat, Marwick, Mitchell & Co. as amicus curiae urging reversal. Briefs of amici curiae were filed by Edward J. Ross and Charles W. Boand for Arthur Anderson & Co.; and by John L. Warden, Philip K. Howard, and William J. Fitzpatrick for the Securities Industry Association. JUSTICE MARSHALL delivered the opinion of the Court. These consolidated cases raise two unresolved questions concerning 10(b) of the Securities Exchange Act of 1934 (1934 Act), 48 Stat. 891, 15 U.S.C. 78j(b). The first is whether purchasers of registered securities who allege they were defrauded by misrepresentations in a registration statement may maintain an action under 10(b) notwithstanding the express remedy for misstatements and omissions in registration statements provided by 11 of the Securities Act of 1933 (1933 Act), 48 Stat. 82, as amended, 15 U.S.C. 77k. The second question is whether persons seeking recovery under 10(b) must prove their cause of action by clear and convincing evidence rather than by a preponderance of the evidence. I In 1969 Texas International Speedway, Inc. (TIS), filed a registration statement and prospectus with the Securities and Exchange Commission offering a total of $4,398,900 in securities to the public. The proceeds of the sale were to be used to finance the construction of an automobile speedway. The entire issue was sold on the offering date, October 30, 1969. TIS did not meet with success, however, and the corporation filed a petition for bankruptcy on November 30, 1970. [Page 459 U.S. 375, 378] In 1972 plaintiffs Huddleston and Bradley instituted a class action in the United States District Court for the Southern District of Texas[Footnote 1] on behalf of themselves and other purchasers of TIS securities. The complaint alleged violations of 10(b) of the 1934 Act and SEC Rule 10b-5 promulgated thereunder, 17 CFR 240.10b-5 (1982).[Footnote 2] Plaintiffs sued most of the participants in the offering, including the accounting firm, Herman & MacLean, which had issued an opinion concerning certain financial statements and a pro forma balance sheet[Footnote 3] that were contained in the registration statement and prospectus. Plaintiffs claimed that the defendants had engaged in a fraudulent scheme to misrepresent or conceal material facts regarding the financial condition of TIS, including the costs incurred in building the speedway. After a 3-week trial, the District Judge submitted the case to the jury on special interrogatories relating to liability. The judge instructed the jury that liability could be found only if the defendants acted with scienter.[Footnote 4] The judge also instructed the jury to determine whether plaintiffs had proved their cause of action by a preponderance of the evidence. [Page 459 U.S. 375, 379] After the jury rendered a verdict in favor of the plaintiffs on the submitted issues, the judge concluded that Herman & MacLean and others had violated 10(b) and Rule 10b-5 by making fraudulent misrepresentations in the TIS registration statement.[Footnote 5] The court then determined the amount of damages and entered judgment for the plaintiffs. On appeal, the United States Court of Appeals for the Fifth Circuit held that a cause of action may be maintained under 10(b) of the 1934 Act for fraudulent misrepresentations and omissions even when that conduct might also be actionable under 11 of the 1933 Act. 640 F.2d 534, 540-543 (1981). However, the Court of Appeals disagreed with the District Court as to the appropriate standard of proof for an action under 10(b), concluding that a plaintiff must prove his case by "clear and convincing" evidence. Id., at 545-546. The Court of Appeals reversed the District Court's judgment on other grounds and remanded the case for a new trial. Id., at 547-550, 560. We granted certiorari to consider whether an implied cause of action under 10(b) of the 1934 Act will lie for conduct subject to an express civil remedy under the 1933 Act, an issue we have previously reserved,[Footnote 6] and to decide the standard of proof applicable to actions under 10(b).[Footnote 7] 456 U.S. 914 [Page 459 U.S. 375, 380] (1982). We now affirm the Court of Appeals' holding that plaintiffs could maintain an action under 10(b) of the 1934 Act, but we reverse as to the applicable standard of proof. II The Securities Act of 1933 and the 1934 Act "constitute interrelated components of the federal regulatory scheme governing transactions in securities." Ernst & Ernst v. Hochfelder, 425 U.S. 185, 206 (1976). The Acts created several express private rights of action,[Footnote 8] one of which is contained in 11 of the 1933 Act. In addition to the private actions created explicitly by the 1933 and 1934 Acts, federal courts have implied private remedies under other provisions of the two laws.[Footnote 9] Most significantly for present purposes, a private right of action under 10(b) of the 1934 Act and Rule 10b-5 has been consistently recognized for more than 35 years.[Footnote 10] The existence of this implied remedy is simply beyond peradventure. [Page 459 U.S. 375, 381] The issue in this case is whether a party should be barred from invoking this established remedy for fraud because the allegedly fraudulent conduct would apparently also provide the basis for a damages action under 11 of the 1933 Act.[Footnote 11] The resolution of this issue turns on the fact that the two provisions involve distinct causes of action and were intended to address different types of wrongdoing. Section 11 of the 1933 Act allows purchasers of a registered security to sue certain enumerated parties in a registered offering when false or misleading information is included in a registration statement. The section was designed to assure compliance with the disclosure provisions of the Act by imposing a stringent standard of liability[Footnote 12] on the parties who [Page 459 U.S. 375, 382] play a direct role in a registered offering.[Footnote 13] If a plaintiff purchased a security issued pursuant to a registration statement, he need only show a material misstatement or omission to establish his prima facie case. Liability against the issuer of a security is virtually absolute,[Footnote 14] even for innocent misstatements. Other defendants bear the burden of demonstrating due diligence. See 15 U.S.C. 77k(b). Although limited in scope, 11 places a relatively minimal burden on a plaintiff. In contrast, 10(b) is a "catchall" antifraud provision,[Footnote 15] but it requires a plaintiff to carry a heavier burden to establish a cause of action. While a 11 action must be brought by a purchaser of a registered security, must be based on misstatements or omissions in a registration statement, and can only be brought against certain parties, a 10(b) action can be brought by a purchaser or seller of "any security" against "any person" who has used "any manipulative or deceptive device or contrivance" in connection with the purchase or sale of a security. 15 U.S.C. 78j (emphasis added). However, a 10(b) plaintiff carries a heavier burden than a 11 plaintiff. Most significantly, he must prove that the defendant acted with scienter, i. e., with intent to deceive, manipulate, or defraud.[Footnote 16] Since 11 and 10(b) address different types of wrongdoing, we see no reason to carve out an exception to 10(b) for fraud occurring in a registration statement just because the [Page 459 U.S. 375, 383] same conduct may also be actionable under 11.[Footnote 17] Exempting such conduct from liability under 10(b) would conflict with the basic purpose of the 1933 Act: to provide greater protection to purchasers of registered securities. It would be anomalous indeed if the special protection afforded to purchasers in a registered offering by the 1933 Act were deemed to deprive such purchasers of the protections against manipulation and deception that 10(b) makes available to all persons who deal in securities. While some conduct actionable under 11 may also be actionable under 10(b), it is hardly a novel proposition that the 1934 Act and the 1933 Act "prohibit some of the same conduct." United States v. Naftalin, 441 U.S. 768, 778 (1979) (applying 17(a) of the 1933 Act to conduct also prohibited by 10(b) of the 1934 Act in an action by the SEC). "`The fact that there may well be some overlap is neither unusual nor unfortunate.'" Ibid., quoting SEC v. National Securities, Inc., 393 U.S. 453, 468 (1969). In saving clauses included in the 1933 and 1934 Acts, Congress rejected the notion that the express remedies of the securities laws would pre-empt all other rights of action. Section 16 of the 1933 Act states unequivocally that "[t]he rights and remedies provided by this title shall be in addition to any and all other rights and remedies that may exist at law or in equity." 15 U.S.C. 77p. Section 28(a) of the 1934 Act contains a parallel provision. 15 U.S.C. 78bb(a). These provisions confirm that the remedies in each Act were to be supplemented by "any and all" additional remedies. This conclusion is reinforced by our reasoning in Ernst & Ernst v. Hochfelder, which held that actions under 10(b) require proof of scienter and do not encompass negligent conduct. In so holding, we noted that each of the express civil [Page 459 U.S. 375, 384] remedies in the 1933 Act allowing recovery for negligent conduct is subject to procedural restrictions not applicable to a 10(b) action.[Footnote 18] 425 U.S., at 208-210. We emphasized that extension of 10(b) to negligent conduct would have allowed causes of action for negligence under the express remedies to be brought instead under 10(b), "thereby nullify[ing] the effectiveness of the carefully drawn procedural restrictions on these express actions." Id., at 210 (footnote omitted). In reasoning that scienter should be required in 10(b) actions in order to avoid circumvention of the procedural restrictions surrounding the express remedies, we necessarily assumed that the express remedies were not exclusive. Otherwise there would have been no danger of nullification. Conversely, because the added burden of proving scienter attaches to suits under 10(b), invocation of the 10(b) remedy will not "nullify" the procedural restrictions that apply to the express remedies.[Footnote 19] This cumulative construction of the remedies under the 1933 and 1934 Acts is also supported by the fact that, when Congress comprehensively revised the securities laws in 1975, a consistent line of judicial decisions had permitted plaintiffs to sue under 10(b) regardless of the availability of express remedies. In 1975 Congress enacted the "most substantial and significant revision of this country's Federal securities laws since the passage of the Securities Exchange [Page 459 U.S. 375, 385] Act in 1934."[Footnote 20] See Securities Acts Amendments of 1975, Pub. L. 94-29, 89 Stat. 97. When Congress acted, federal courts had consistently and routinely permitted a plaintiff to proceed under 10(b) even where express remedies under 11 or other provisions were available.[Footnote 21] In light of this [Page 459 U.S. 375, 386] well-established judicial interpretation, Congress' decision to leave 10(b) intact suggests that Congress ratified the cumulative nature of the 10(b) action. See Merrill Lynch, Pierce, Fenner & Smith, Inc. v. Curran, 456 U.S. 353, 381-382 (1982); Lorillard v. Pons, 434 U.S. 575, 580-581 (1978). A cumulative construction of the securities laws also furthers their broad remedial purposes. In enacting the 1934 Act, Congress stated that its purpose was "to impose requirements necessary to make [securities] regulation and control reasonably complete and effective." 15 U.S.C. 78b. In furtherance of that objective, 10(b) makes it unlawful to use "any manipulative or deceptive device or contrivance" in connection with the purchase or sale of any security. The effectiveness of the broad proscription against fraud in 10(b) would be undermined if its scope were restricted by the existence of an express remedy under 11.[Footnote 22] Yet we have repeatedly recognized that securities laws combating fraud should be construed "not technically and [Page 459 U.S. 375, 387] restrictively, but flexibly to effectuate [their] remedial purposes." SEC v. Capital Gains Research Bureau, Inc., 375 U.S. 180, 195 (1963). Accord, Superintendent of Insurance v. Bankers Life & Cas. Co., 404 U.S. 6, 12 (1971); Affiliated Ute Citizens v. United States, 406 U.S. 128, 151 (1972). We therefore reject an interpretation of the securities laws that displaces an action under 10(b).[Footnote 23] Accordingly, we hold that the availability of an express remedy under 11 of the 1933 Act does not preclude defrauded purchasers of registered securities from maintaining an action under 10(b) of the 1934 Act. To this extent the judgment of the Court of Appeals is affirmed. III In a typical civil suit for money damages, plaintiffs must prove their case by a preponderance of the evidence.[Footnote 24] Similarly, in an action by the SEC to establish fraud under 17(a) of the 1933 Act, 15 U.S.C. 77q(a), we have held that proof by a preponderance of the evidence suffices to establish liability. SEC v. C. M. Joiner Leasing Corp., 320 U.S. 344, 355 (1943). "Where . . . proof is offered in a civil action, as here, a preponderance of the evidence will establish the case . . . ." [Page 459 U.S. 375, 388] Ibid. The same standard applies in administrative proceedings before the SEC[Footnote 25] and has been consistently employed by the lower courts in private actions under the securities laws.[Footnote 26] The Court of Appeals nonetheless held that plaintiffs in a 10(b) suit must establish their case by clear and convincing evidence. The Court of Appeals relied primarily on the traditional use of a higher burden of proof in civil fraud actions at common law. 640 F.2d, at 545-546. Reference to common-law practices can be misleading, however, since the historical considerations underlying the imposition of a higher standard of proof have questionable pertinence here.[Footnote 27] See Blue Chip Stamps v. Manor Drug Stores, 421 U.S. 723, 744-745 (1975) ("[T]he typical fact situation in which the classic tort of misrepresentation and deceit evolved was light years away from the world of commercial transactions to which Rule 10b-5 is applicable"). Moreover, the antifraud provisions of the securities laws are not coextensive with [Page 459 U.S. 375, 389] common-law doctrines of fraud.[Footnote 28] Indeed, an important purpose of the federal securities statutes was to rectify perceived deficiencies in the available common-law protections by establishing higher standards of conduct in the securities industry. See SEC v. Capital Gains Research Bureau, Inc., supra, at 186. We therefore find reference to the common law in this instance unavailing. Where Congress has not prescribed the appropriate standard of proof and the Constitution does not dictate a particular standard, we must prescribe one. See Steadman v. SEC, 450 U.S. 91, 95 (1981). See generally Blue Chip Stamps v. Manor Drug Stores, supra, at 749 (private cause of action under 10(b) and Rule 10b-5 must be judicially delimited until Congress acts). In doing so, we are mindful that a standard of proof "serves to allocate the risk of error between the litigants and to indicate the relative importance attached to the ultimate decision." Addington v. Texas, 441 U.S. 418, 423 (1979). See also In re Winship, 397 U.S. 358, 370-371 (1970) (Harlan, J., concurring). Thus, we have required proof by clear and convincing evidence where particularly important individual interests or rights are at stake. See, e. g., Santosky v. Kramer, (1982) (proceeding to terminate parental rights); Addington v. Texas, supra (involuntary commitment proceeding); Woodby v. INS, 385 U.S. 276, 285-286 (1966) (deportation).[Footnote 29] By contrast, imposition of even severe civil sanctions that do not implicate such interests has been permitted after proof by a [Page 459 U.S. 375, 390] preponderance of the evidence. See, e. g., United States v. Regan,If you are already a vLex customer, access here
This document cites
- U.S. Court of Appeals for the 2nd Cir. - Fed. Sec. L. Rep. P 92,474 Morton Globus Et Al., Plaintiffs-Appellees, v. Law Research Service, Inc. and Ellias C. Hoppenfeld, Defendants-Appellants. Blair & Co., Granbery Marache Incorporated, Defendant-Appellant and Third-Party Plaintiff-Appellant, v. Paul Wiener, Third-Party Defendant-Appellee., 418 F.2d 1276 (2nd Cir. 1970)
- U.S. Court of Appeals for the 4th Cir. - Fed. Sec. L. Rep. P 97,515 Dan River, Inc., Appellant, v. Unitex Limited; Mannip Limited; Cheng Fur She; Cheng Lee Kit-Yiu; Philip Y. S. Cheng; Lee Chen Che; Liu Han Tang; Yang Yuan Loong; Dora Yang; the 'Roe' Bank of Hong Kong; the 'Doe' Finance Company of Hong Kong; 'Xyz' Company, Appellees., 624 F.2d 1216 (4th Cir. 1980)
- U.S. Court of Appeals for the 2nd Cir. - Fischman Et Al. v. Raytheon Mfg. Co. Et Al., 188 F.2d 783 (2nd Cir. 1951)
- U.S. Supreme Court - Piper v. Chris-Craft Industries, Inc., 430 U.S. 1 (1977)
- U.S. Court of Appeals for the 7th Cir. - Robert Schaefer and Sandra Schaefer, Plaintiffs-Appellants, v. First National Bank of Lincolnwood Et Al., Defendants-Appellees., 509 F.2d 1287 (7th Cir. 1975)
- U.S. Court of Appeals for the 2nd Cir. - Fed. Sec. L. Rep. P 97,320 Iit, an International Investment Trust, and Georges Baden, Jacques Delvaux and Ernest Lecuit, as Liquidators for Iit, an International Investment Trust, Plaintiffs-Appellants, v. Bernard Cornfeld, Carl Johan Bernadotte, Martin Brooke, C. Henry Buhl, Iii, Joop Melse, Erich Mende, Beat Notz, Pierre Rinfret, James Roosevelt, Melvin Rosen, Barry Sterling, Moritz Von Hessen, Henry Von Maur, Arthur Lipper Corporation, Arthur Lipper, Iii, Arthur Andersen & Co., James E. Bye, Stanley B. Hallman, James B. Kuhn, Lawrence Ocrant, E. Keene Wolcott, Adams & Peck, Bear, Stearns & Co., Burnham and Company, Emanual Deetjen & Co., Irving Lundborg & Co., Burnham & Company, Incorporated, Drexel Burnham & Co., Inc. and Does 1 Through 10, Defendants- Appellees., 619 F.2d 909 (2nd Cir. 1980) 320 Iit, an International Investment Trust, and Georges Baden, Jacques Delvaux and Ernest Lecuit, as Liquidators for Iit, an International Investment Trust, Plaintiffs-Appellants, v. Bernard Cornfeld, Carl Johan Bernadotte, Martin Brooke, C. Henry Buhl, Iii, Joop Melse, Erich Mende, Beat Notz, Pierre Rinfret, James Roosevelt, Melvin Rosen, Barry Sterling, Moritz Von Hessen, Henry Von Maur, Arthur Lipper Corporation, Arthur Lipper, Iii, Arthur Andersen & Co., James E. Bye, Stanley B. Hallman, James B. Kuhn, Lawrence Ocrant, E. Keene Wolcott, Adams & Peck, Bear, Stearns & Co., Burnham and Company, Emanual Deetjen & Co., Irving Lundborg & Co., Burnham & Company, Incorporated, Drexel Burnham & Co., Inc. and Does 1 Through 10, Defendants- Appellees.
See other documents that cite the same legislation
